URGN Reports $29.2M ZUSDURI Revenue, 109% QoQ Growth, $21.7M JELMYTO Revenue, 7% YoY Growth
UroGen Pharma Ltd. Ordinary Shares · PHARMACEUTICAL PREPARATIONS · Now $27.03
+19% in 3d after detection
Post-detection moves
1h
—
1d
+1.3%
3d
+19%
7d
+9.6%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS